Skip to main content
SpringerLink
Log in

Complete Freund's Adjuvant Promotes the Increases of IFN-γ and Nitric Oxide in Suppressing Chronic Arthritis Induced by Pristane

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The aim of this study was to determine therapeutic effects of complete Freund's adjuvant (CFA) on the progression and relapsing of pristine-induced arthritis (PIA) and investigate the mechanism involved. Chronic relapsing arthritis was induced by pristine in LEW rats. After onset of arthritis, rats were intradermally injected CFA and rats in control group were injected the same volume of PBS. Arthritis was monitored visually, and joint pathology was examined histologically. Cytokine mRNA expression in inguinal lymph nodes was assessed by RT-PCR. The levels of nitric oxide (NO) in serum were measured by colorimetric assay. The results showed that CFA significantly suppressed the progression and relapsing of PIA. Relapsing rate of PIA in CFA-treated group was 12.5% and it was 85.7% in PBS-control group (P < 0.005). CFA markedly inhibited the infiltration of inflammatory cells and cartilage damage in the joints of CFA-treated rats and promoted the increases of IFN-γ mRNA and NO levels. The present study provided an implication that adjuvant therapy may be a new strategy for the treatments of rheumatoid arthritis (RA) and other chronic inflammatory diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brooks, P. 1993. Clinical management of rheumatoid arthritis. Lancet 341:286–290.

    Google Scholar 

  2. Bresnihan, B., J. M. Alvaro-Gracia, M. Cobby, M. Doherty, Z. Domljan, P. Emery, et al. 1998. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 41:2196–2204.

    Google Scholar 

  3. Elliott, M., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, H. Biji, et al. 1994. Repeated therapy with monoclonal antibody to tumor necrosis factor-α (cA2) in patients with rheumatoid arthritis. Lancet 344:1125–1127.

    Google Scholar 

  4. Van Roon, J. A., F. P. Lafeber, and J. W. Bijlsma. 2001. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum. 44:3–12.

    Google Scholar 

  5. Cobelens, P. M., C. J. Heijnen, E. E. Nieuwenhuis, P. P. Kramer, R. van der Zee, W. van Eden, et al. 2000. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp 65 during disease. Arthritis Rheum. 43:2694–2702.

    Google Scholar 

  6. Muto, Y., J. Satoh, G. Muto, T. Msuda, M. Sagara, M. Fukuzawa, et al. 1997. Effect of long-term treatment with complete Freund's adjuvant on kk-ay mouse, a model of non-dependent diabetes mellitus. Clin. Immunol. Immunopathol. 83:53–59.

    Google Scholar 

  7. Shehadeh, N., F. Calcinaro, B. J. Bradley, I. Bruchlim, and K. J. Lafferty. 1994. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706–707.

    Google Scholar 

  8. Kahn, G., M. G. Buzzi, U. Sabatini, E. Giugni, S. Bastianello, F. Viselli, et al. 1999. Use of bacilli calmette-guerin (BCG) in multiple sclerosis. Neurology 53:1588–1589.

    Google Scholar 

  9. Kahn, D., D. C. Archer, D. P. Gold, and C. J. Kelly. 2001. Adjuvant immunotherapy is dependent on inducible nitric oxide synthase. J. Exp. Med. 193:1261–1267.

    Google Scholar 

  10. Balagon, M. V., D. S. Walsh, P. L. Tan, R. V. Cellona, R. M. Abalos, E. V. Tan, et al. 2000. Improvement in psoriasis after intradermal administration of heat-killed mycobacterium vaccae. Int. Dermatol. 39:51–58.

    Google Scholar 

  11. Wooley, P., S. Sud, J. D. Whalen, and S. Nasser. 1998. Pristane-induced arthritis in mice. Arthritis Rheum. 41:2022–2031.

    Google Scholar 

  12. Vingsbo, C., P. Sahlstrand, J. G. Brun, R. Jonsson, T. Saxne, and R. Halmdahl. 1996. Pristane-induced arthritis in rats: A new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149:1675–1683.

    Google Scholar 

  13. Wooley, P., J. R. Seibold, J. D. Whalen, and J. M. Chapdelaine. 1989. Pristane-induced arthritis: The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum. 32:1022–1030.

    Google Scholar 

  14. Staiuk, L. M., M. Choraishian, J. Elson, and S. J. Thompson. 1997. Pristane-induced arthritis is CD4+T cell dependent. Immunology 90:81–86.

    Google Scholar 

  15. Trentham, D.E., A. S. Townes, and A. H. Kang. 1997. Autoimmunity to type II collagen: An experiment model of arthritis. J. Exp. Med. 146:857–868.

    Google Scholar 

  16. Tso, J. Y., X. H. Sun, T. H. Kao, K. S. Reece, and R. Wu. 1985. Isolation and characterization of rat human glyceraldehydes-3-phosphate dehydrogenase cDNA: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2486–2502.

    Google Scholar 

  17. Schmidt-Weber, C. B., D. Pohlers, A. Siegling, H. Schadlich, E. Buchner, H. D.y Volk, et al. 1999. Cytokinegeneactivationinsynovial membrane regional lymph nodes, spleen during the course of rat adjuvant arthritis. Cell Immunol. 195:53–65.

    Google Scholar 

  18. Zipris, T., D. L. Greiner, S. Malkani, B. Whalen, J. P. Mordes, and A. A. Rossini. 1999. Cytokine gene expression in islets and thyroids of BB rats. J. Immunol. 156:1315–1321.

    Google Scholar 

  19. Zhang, H., T. Morisaki, H. Matsunaga, N. Sato, A. Uchiyama, K. Hashizume, et al. 2000. Protein-bound polysaccharide PKS inhibits tumor invasiveness by down-regulation of TGF-b and MMPs. Clin. Exp. Metastasis 18:343–352.

    Google Scholar 

  20. Trembleau, S., T. Germann, M. K. Gately, and L. Adorini. 1995. The role of IL-2 in the induction of organ-specific autoimmune disease. Immunol. Today 16:383–386.

    Google Scholar 

  21. Cooper, S. M., S. Sriram, and G. E. Ranges. 1988. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-γ. J. Immunol. 141:1958–1962.

    Google Scholar 

  22. Williams, R. O., D. G. Williams, M. Feldmann, and R. N. Maini. 1993. Increasedlimbinvolvementinmurinecollagen-inducedarthri-tis following treatment with anti-interferon-gamma. Clin. Exp. Immumol. 92:323–327.

    Google Scholar 

  23. Manoury-Schwartz, B., G. Chiocchia, N. Bessis, O. Abehsira-Amar, F. Batteux, S. Muller, et al. 1997. High susceptibity to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol. 158:5501–5506.

    Google Scholar 

  24. Wiesenberg, I., P. H. Van der Meide, H. Schellebens, and S. S. Alkan. 1989. Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin. Exp. Immunol. 78:245–249.

    Google Scholar 

  25. Fox, S. W. and T. J. Chambers. 2000. Interferon-γ directly inhibits TRANCE-induced osteoclastogenesis. Biochem. Biophys. Res. Commun. 276:868–872.

    Google Scholar 

  26. Takayanayi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408:600–605.

    Google Scholar 

  27. Alvaro-Gracia, J. M., N. J. Zvaifler, and G. S. Firestein. 1990. Cytokines in chronic inflammatory arthritis. V: Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86:1790–1798.

    Google Scholar 

  28. Guedez, Y. B., K. B. Whittington, J. L. Clayton, L. B. Joosten, F. J. Van de Loo, W. B. van den Berg, and E. F. Rosloniec. 2001. Genedtic ablation of interferon-γ up-regulates interleukin-1β expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum. 44:2413–2424.

    Google Scholar 

  29. Sicher, S C., M. A. Vazques, and C. Y. Lu. 1994. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1293–1300.

    Google Scholar 

  30. Tavares-Murta, B. M., J. S. Machado, S. H. Ferreira, and F. Q. Cunha. 2001. Nitric oxide mediates the inhibition of neutrophil migration induced by systemic administration of LPS. Inflammation 25:247–253.

    Google Scholar 

  31. De Caterina, R. P., P. Libby, H. B. Ping, V. J. Thannickal, T. B. Rajavsahisth, M. A. Gimbrone, et al. 1995. Nitric oxide decreased cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60–68.

    Google Scholar 

  32. Sandi, C., and C. Gauza. 1995. Evidence for nitric oxide in the corticotropin-releasing factor release induced by interleukin-1β. Eur. J. Pharmacol. 274:17–23.

    Google Scholar 

  33. Arnett, A. A., R. P. Hellendall, G. K. Matsushima, K. Suzuki, V. E. Laubach, P. Sherman, et al. 2002. The protective role of nitric oxide in a neurotoxicant-induced demyelinating model. J. Immunol. 168:427–433.

    Google Scholar 

  34. Veihelmann, A., J. Landes, A. Hofbauer, M. Dorger, H. J. Refior, K. Messmer, et al. 2001. Exacerbation of antigen-induced arthritis in inducible nitric oxide synthase-deficient mice. Arthritis Rheum. 44:1420–1427.

    Google Scholar 

  35. Billigham, M. E. 1995. Mechanism and models in rheumatoid arthritis. ISBN 0–12–340440–1384–409.

  36. Tsukano, M., Y. Nawa, and M. Kotani. 1983. Characterization of low dose induced suppressor cells in adjuvant arthritis in rats. Clin. Exp. Immunol. 53:60–66.

    Google Scholar 

  37. Qin, H. Y., M. W. Sadelain, C. Hitchon, J. Lauzon, and B. Shigh. 1993. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150:2072–2080.

    Google Scholar 

  38. Zheng, C. L., M. A. Hossiain, A. Kukita, K. Ohki, T. Satoh, and O. Kohashi. 2002. Complete Freund's adjuvant suppresses the development and progression of pristane-induced arthritis in rats. Clin Immunol 103:204–209.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, Saga Medical School, Nabeshima, Saga, Japan

    Cong-Long Zheng, Kazunori Ohki, Md. Aslam Hossain, Akiko Kukita, Toshimi Satoh & Osamu Kohashi

Authors
  1. Cong-Long Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazunori Ohki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Md. Aslam Hossain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Akiko Kukita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshimi Satoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Osamu Kohashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cong-Long Zheng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zheng, CL., Ohki, K., Hossain, M.A. et al. Complete Freund's Adjuvant Promotes the Increases of IFN-γ and Nitric Oxide in Suppressing Chronic Arthritis Induced by Pristane. Inflammation 27, 247–255 (2003). https://doi.org/10.1023/A:1025092615584

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025092615584

Search

Navigation